{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:52:47Z","timestamp":1790891567871,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1053\/j.semtcvs.2008.03.001","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T12:47:01Z","timestamp":1220964421000},"page":"131-137","source":"Crossref","is-referenced-by-count":43,"title":["Current Status and Future Prospects for Cell Transplantation to Prevent Congestive Heart Failure"],"prefix":"10.1053","volume":"20","author":[{"given":"Philippe","family":"Menasch\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2008.03.001_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.105.590653","article-title":"Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair","volume":"114","author":"Boyle","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib2","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.athoracsur.2006.05.047","article-title":"Repair of the damaged heart by bone marrow cells: from experimental evidence to clinical hope","volume":"82","author":"Ang","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(00)03617-5","article-title":"Myoblast transplantation for heart failure","volume":"357","author":"Menasche","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasch\u00e9","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtcvs.2005.11.030","article-title":"Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up","volume":"131","author":"Gavira","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ahj.2004.03.043","article-title":"Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up","volume":"148","author":"Siminiak","year":"2004","journal-title":"Am Heart J"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib7","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.105.547810","article-title":"Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up","volume":"112","author":"Dib","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cardiores.2005.10.003","article-title":"Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias","volume":"69","author":"Fernandes","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib9","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1073\/pnas.1232447100","article-title":"Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host","volume":"100","author":"Leobon","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.RES.0000174794.22491.a0","article-title":"Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation","volume":"97","author":"Abraham","year":"2005","journal-title":"Circ Res"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib11","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.106.662577","article-title":"Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model","volume":"115","author":"Fukushima","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.healun.2007.10.011","article-title":"The real estate of myoblast cardiac transplantation: negative remodeling is associated with location","volume":"27","author":"McCue","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 1","key":"10.1053\/j.semtcvs.2008.03.001_bib13","first-page":"I108","article-title":"Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients","volume":"114","author":"Hagege","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial","volume":"117","author":"Menasch\u00e9","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/eurheartj\/ehi159","article-title":"Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial","volume":"26","author":"Siminiak","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejheart.2005.12.004","article-title":"Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischemic heart failure","volume":"8","author":"Biagini","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1583\/04-1386R.1","article-title":"Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction","volume":"11","author":"Ince","year":"2004","journal-title":"J Endovasc Ther"},{"issue":"suppl","key":"10.1053\/j.semtcvs.2008.03.001_bib18","first-page":"II-88","article-title":"Safety and feasibility of percutaneous autologous skeletal myoblast transplantation for ischemic cardiomyopathy: Six-month interim analysis","volume":"114","author":"Dib","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3727\/000000004772664842","article-title":"Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans","volume":"13","author":"Galinanes","year":"2004","journal-title":"Cell Transplant"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ahj.2005.02.001","article-title":"Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting","volume":"151","author":"Mocini","year":"2006","journal-title":"Am Heart"},{"issue":"suppl 1","key":"10.1053\/j.semtcvs.2008.03.001_bib21","first-page":"I101","article-title":"Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial","volume":"114","author":"Hendrikx","year":"2006","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1053\/j.semtcvs.2008.03.001_bib22","first-page":"II247","article-title":"Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution","volume":"108","author":"Bel","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","article-title":"Potential risks of bone marrow cell transplantation into infarcted hearts","volume":"110","author":"Breitbach","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","article-title":"Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies","volume":"133","author":"Stamm","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11 suppl 1","key":"10.1053\/j.semtcvs.2008.03.001_bib25","first-page":"II213","article-title":"Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy","volume":"110","author":"Perin","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib26","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2005.01.069","article-title":"Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study","volume":"46","author":"Strauer","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib27","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib28","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.jacc.2007.01.095","article-title":"Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure","volume":"49","author":"Kissel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.RES.0000264508.47717.6b","article-title":"TOPCARE-CHD Registry","volume":"100","author":"Assmus","year":"2007","journal-title":"Circ Res"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib30","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2007.06.009","article-title":"Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation","volume":"50","author":"Kan","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1083\/jcb.200612094","article-title":"A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency","volume":"177","author":"Deasy","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm (Lond)"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib33","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2006.02.002","article-title":"Regeneration gaps","volume":"47","author":"Murry","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1053\/j.semtcvs.2008.03.001_bib34","first-page":"II259","article-title":"Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers","volume":"108","author":"Tambara","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jss.2007.03.021","article-title":"Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation","volume":"142","author":"Hudson","year":"2007","journal-title":"J Surg Res"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib36","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","article-title":"Monitoring of bone marrow cell homing into the infarcted human myocardium","volume":"111","author":"Hofmann","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/cvr\/cvm027","article-title":"Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells","volume":"77","author":"Lutz","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib38","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/CIRCULATIONAHA.106.628623","article-title":"Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia","volume":"114","author":"Aicher","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib39","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jacc.2005.05.052","article-title":"Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction","volume":"46","author":"Yoshida","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pcad.2007.02.002","article-title":"Skeletal myoblasts as a therapeutic agent","volume":"50","author":"Menasche","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jtcvs.2005.07.023","article-title":"Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets","volume":"130","author":"Memon","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl I","key":"10.1053\/j.semtcvs.2008.03.001_bib42","first-page":"I38","article-title":"Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium","volume":"116","author":"Amsalem","year":"2007","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1634\/stemcells.2006-0374","article-title":"Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines","volume":"25","author":"Ebelt","year":"2007","journal-title":"Stem Cells"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib44","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"14","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1999.tb08493.x","article-title":"Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications","volume":"875","author":"Dautzenberg","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib46","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.106.657270","article-title":"Theoretical impact of the injection of material into the myocardium: a finite element model simulation","volume":"114","author":"Wall","year":"2006","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jmcc.2001.1507","article-title":"Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting","volume":"34","author":"Reinecke","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"issue":"suppl 9","key":"10.1053\/j.semtcvs.2008.03.001_bib49","first-page":"II332","article-title":"Transplantation of fetal myocardial tissue into the infarcted myocardium of rat","volume":"94","author":"Leor","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib50","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jtcvs.2007.10.024","article-title":"Cardiac stem cells in the real world","volume":"135","author":"Pouly","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib51","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1634\/stemcells.2007-0133","article-title":"Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats","volume":"25","author":"Tomescot","year":"2007","journal-title":"Stem Cells"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","article-title":"Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts","volume":"26","author":"Nakagawa","year":"2008","journal-title":"Nat Biotech"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib53","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexeiezumab, an anti-C5a complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2008.03.001_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","year":"2007","journal-title":"JAMA"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067908000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067908000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T01:28:59Z","timestamp":1545787739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067908000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1043067908000439"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2008.03.001","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}